Providing patient-centered education and navigation support significantly increases consent rates for genomic testing, making ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment.

Breast cancer is the most common cancer among women, making up 30% of all new cases each year. Knowledge is power when it comes to detection and prevention of this disease: Genetic testing can play an ...

Genetic testing could provide critical health information, but it may not be right for everyone. NBC’s medical contributor Dr ...

A review of the distribution of risk estimates from three commonly used genomic assays for breast cancer found that Black women were more likely to have aggressive tumor phenotypes, which contributed ...

The U.S. Food and Drug Administration (FDA) has approved Guardant360 CDx as a companion diagnostic to identify patients with ...

A nationwide Australian pilot screened more than 10,000 adults aged 18–40 years for high-risk genetic variants linked to ...

Leading genomic health experts from Monash University are calling for urgent government funding to progress the development ...

An affordable new BRCA gene test has hit the market, but who should take it? — -- A new genetic testing kit that hits the market today is the most affordable, and arguably one of the simplest, ...

Komen(R), the world's leading breast cancer organization, commends Senator Ana Maria Rodriguez (R-Doral) and Representative Marie Woodson (D-Pembroke Pines) for introducing legislation that would ...

In 2023, Jill Martin took a test that changed her life. She underwent genetic testing for breast cancer and learned she had a BRCA2 mutation, which increases one’s risk of developing breast and other ...